Case Studies > Self-injectable contraception
COUCH Health partnered with a biopharma company to gain insights into healthcare professional (HCP) and consumer perspectives and barriers towards a self-injectable birth control in low- and middle-income countries.
The insights generated through in-depth interviews, along with COUCH Health’s recommendations for key considerations and actionable solutions, were used to inform a new implementation strategy for a self-injectable contraceptive.
Cultural norms and religious beliefs in Nigeria, India, and Pakistan may heavily influence the accessibility and acceptance of contraceptive methods, including self-injectable contraceptives.
Fear, pain, and side effects associated with self-injection, coupled with a lack of education among HCPs on specific training techniques, hinder the uptake and prescription of this method.
214 million people able to become pregnant of reproductive age in developing countries who want to avoid pregnancy are not using a modern contraceptive method
COUCH Health conducted in-depth interviews across India, Nigeria, and Pakistan with:
From the research insights obtained, we:
21 interviews conducted – 6 HCPs and 15 consumers
There was diverse representation among participants:
Any form of contraceptive usage
Based on the insights gathered, COUCH Health provided recommendations on key themes:
Consumer education:
Outreach strategies for:
Advertising on:
HCP education:
These insights and recommendations were used to inform the implementation strategy for a self-injectable contraceptive.
UK address
COUCH Health
5 Richmond Street
Manchester, M1 3HF
+44 (0) 161 300 0874
US address
1111B S Governors Ave
STE 21906,
Dover, DE 19904
+1 321 985 1511
hello@couchhealth.agency
Receive exclusive insights from our experts on important topics and news within the inclusive clinical research space.